
Sandoz challenges Amgen’s Enbrel patents in US antitrust lawsuit
Sandoz has filed an antitrust lawsuit in the US against Amgen, challenging alleged anti-competitive practices surrounding the biologic blockbuster Enbrel (etanercept). Filed at the US District Court for the Eastern District of Virginia, the suit contends …